News

EMBL-EBI Industry workshop, October 25-26, 2017, Cambridge UK

Bioneer has been invited to speak at the upcoming EMBL-EBI symposium/workshop about "Genome Editing in Drug Discovery & Development". Each topic in the workshop series has been chosen by the members.

Bioneer has been working with applied stem cell technologies since 2006, and has for the last many years applied gene editing technology in various research projects. Bioneer has an established national iPSC core facility that operates in a variety of national and international research programs, and is currently partner in the IMI funded project European Bank for induced pluripotent Stem Cells (EBiSC).

The EMBL-EBI Industry Programme Members are: Abbvie, Astellas, Astex Pharmaceuticals, AstraZeneca, Bayer, Bayer CropScience, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Galderma, GSK, Janssen, Lilly, Merck, Medimmune, MSD, Nestlé Institute of Health Sciences, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Syngenta, Takeda, Ucb, and Unilever.

Read more about the EMBL-EBI Industry Workshops here.